Validated for Alpha (U.K.), Beta (South Africa), Gamma (Brazil), Delta (India), Eta (Nigeria), Iota (USA), Kappa (India), Lambda (Peru), P.2 (Brazil), B.1.620 and Omicron variants detection
Options for either a nasal or nasopharyngeal swabs
Improved detection line, which has a LoD of 40 TCID50/mL, this implies that tests can detect fewer viruses and the kit’s sensitivity is 97.6%
According to TGA, the kit has been rated as “very highly sensitive”
 
Product Features:
Supports patient management decisions by detecting viral components within first seven days of symptom onset
Sample collection made easier through nasal swab procedure for patient comfort and end-user flexibility
Pre-filled extraction tubes simplify test procedure
94.7% Sensitivity; 100% Specificity
Fast results in 15-20 minutes
Easy to use in point-of-care & resource-limited settings
Compatible with CT's ALTA® Rapid Test Reader (RTR-1)